Abstract CT128: IMU-201-101 - an open-label, multi-center, dose escalation/expansion, phase 1 study of IMU-201 (PD1-Vaxx), a B-cell immunotherapy, in adults with non-small cell lung cancer

2020 ◽  
Author(s):  
Pravin Kaumaya ◽  
Tanios Bekaii-Saab ◽  
Tri Phan ◽  
Mark T. Marino ◽  
Nick Ede ◽  
...  
Keyword(s):  
Lung Cancer ◽  
B Cell ◽  
Dose Escalation ◽  
Phase 1 ◽  
Small Cell ◽  
Small Cell Lung ◽  
Open Label ◽  
Phase 1 Study ◽  
Expansion Phase ◽  
Cell Immunotherapy

Pembrolizumab in patients with advanced non-small-cell lung cancer (KEYNOTE-001): 3-year results from an open-label, phase 1 study

2019 ◽  
Vol 7 (4) ◽  
pp. 347-357 ◽  
Author(s):  
Natasha B Leighl ◽  
Matthew D Hellmann ◽  
Rina Hui ◽  
Enric Carcereny ◽  
Enriqueta Felip ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Phase 1 ◽  
Small Cell ◽  
Small Cell Lung ◽  
Open Label ◽  
Phase 1 Study ◽  
Open Label Phase

scholarly journals Phase 1 Study of Dose Escalation in Hypofractionated Proton Beam Therapy for Non-Small Cell Lung Cancer

2013 ◽  
Vol 86 (4) ◽  
pp. 665-670 ◽  
Author(s):  
Daniel R. Gomez ◽  
Michael Gillin ◽  
Zhongxing Liao ◽  
Caimiao Wei ◽  
Steven H. Lin ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Proton Beam ◽  
Cell Lung Cancer ◽  
Dose Escalation ◽  
Phase 1 ◽  
Proton Beam Therapy ◽  
Small Cell ◽  
Small Cell Lung ◽  
Phase 1 Study
Sign in / Sign up

Export Citation Format

Share Document